TheStreet) -- STOCK COMMENTS / EPS CHANGES Bed Bath & Beyond ( BBBY) price target raised at Citi to $65 from $62. Positive takeaways after meeting with management, Citigroup said. Maintain Buy rating. BE Aerospace ( BEAV) numbers boosted at Goldman. Shares of BEAV now seen reaching $48. Estimates also upped, given the company's record bookings. Buy rating. Cooper Industries ( CBE) numbers upped at Goldman through 2013, Goldman Sachs said. Company is realizing higher organic sales growth. Neutral rating and new $70 price target. CIT Group ( CIT) price target cut at Citi to $55 from $57. Debt refinancing and FSA drive EPS lower, Citigroup said. Maintain Buy rating. ITT Educational ( ESI) numbers raised at Goldman. Shares of ESI now seen reaching $83, according to Goldman Sachs. Estimates also increased, to match the company's new guidance. Neutral rating. Express Scripts ( ESRX) estimates lowered at UBS. ESRX estimates were cut through 2012, UBS said. Company is seeing slower earnings growth. Buy rating and $66 price target. Hecla Mining ( HL) numbers upped at Jefferies. HL estimates were boosted through 2012, Jefferies said. Company should benefit from higher silver prices. Buy rating and new $13 price target. Hexcel ( HXL) estimates, target boosted at Jefferies. Shares of HXL now seen reaching $22, according to Jefferies. Estimates also upped, given higher expected civil aircraft demand. Hold rating. Idex ( IEX) estimates, target raised at UBS. Shares of IEX now seen reaching $50, according to UBS. Estimates also increased, as higher sales is driving margin growth. Neutral rating. Kimberly-Clark ( KMB) numbers lowered at Goldman. Shares of KMB now seen reaching $64. Estimates also reduced, given higher commodity costs. Sell rating. Marriott International ( MAR) estimates reduced at Morgan Stanley through 2012. Company lacks near-term catalysts. Equal-weight rating and $38 price target. Netflix ( NFLX) price target lifted at Citi to $245 from $210 after posting strong 1Q11 results, Citigroup said. Maintain Hold rating. Netflix estimates increased at Goldman through 2013, Goldman Sachs said. Company is realizing higher operating margins. Buy rating and $300 price target. Philip Morris ( PM) price target boosted at Credit Suisse to $72 from $64. Strong growth momentum in Asia, and margin expansion, Credit Suisse said. Estimates raised through 2013. Maintain Outperform rating.
Valueclick ( VCLK) estimates, target increased at UBS. VCLK estimates were raised through 2012. Acquisition should add to earnings. Neutral rating and new $16 price target. Veeco Instruments ( VECO) increased at UBS through 2012. Company is realizing higher orders. Buy rating and new $65 price target. Watson Pharmaceuticals ( WPI) estimates raised at Credit Suisse. WPI 2011 and 2012 EPS estimates raised to $4.20 and $5.37, respectively. Solid volumes and pricing should drive better than expected 1Q results, Credit Suisse said. Maintain Outperform rating and $65 price target. End of report.